Posted by & filed under Company Analysis.

Description: Sanofi-Aventis SA, France’s largest drugmaker, got about $10 billion of underwritten loans to back its bid for U.S. biotechnology company Genzyme Corp., two people familiar with the situation said .

Date: 09/10/2010


Questions for discussion:

  • What does this report have to say about the financial state of some European banks and the firms they are financing?
  • Do you think this report suggests that credit might not be as much of as problem as it has been since the crisis?
  • How should other banks, borrowers, and investors respond to this report?
  • What does this report suggest about current stock market valuations?

Leave a Reply

Your email address will not be published. Required fields are marked *